Australia · Delayed Price · Currency is AUD BLS Pharmaceuticals Company Description
BLS Pharmaceuticals Limited manufactures, imports, exports, and supplies controlled drugs and prescription medicines in Australia, the United Kingdom, Europe, and Japan.
It operates through Manufacture/Sales Australia, Plant Based/UK/EU/JPN/AUS, and Wholesale PCC/USA segments.
The Manufacture/Sales Australia segment engages in the manufacture and wholesale supply of preventive and novel medicines, cannabis, psilocybin, and MDMA under BLS.
The Plant Based/UK/EU/JPN/AUS segment manufactures and distributes consumer health and novel food products under the Dr Watson brand.
The Wholesale PCC/USA segment is involved in wholesale of patented Probiotics for gastrointestinal health and immunity.
It also provides contract manufacturing services; and storage and distribution services. The company was formerly known as Bioxyne Limited and changed its name to BLS Pharmaceuticals Limited in June 2026.
BLS Pharmaceuticals Limited is headquartered in Sydney, Australia
| Country | Australia |
| Founded | 1998 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Samuel Watson |
Contact Details
Address: Level 5 Sydney, NSW 2000 Australia | |
| Phone | 61 2 9078 8180 |
| Website | blspharma.com |
Stock Details
| Ticker Symbol | BLS |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000477796 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Samuel Watson | Chief Executive Officer, MD and Executive Director |
| Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | Chief Financial Officer and Company Secretary |
| Jason Hine | Chief Operating Officer and Executive Director |
| Macdarragh O'Neill | Head of Production of GMP and Director of BLS Wholesalers Pty |